How Thyroid Cancer Cells Use Cytokines to Block Immune Response
Author Information
Author(s): Klemke Matthias, Veit Nadine, Schmidt-Wolf Ingo, Bundschuh Ralph A., Essler Markus, Kreppel Barbara
Primary Institution: University Hospital Bonn
Hypothesis
Thyroid cancer cells actively participate in blocking immune surveillance by secretion of mediators of the innate immune system.
Conclusion
Thyroid carcinoma cells secrete specific cytokines that promote the expression of PDL-1, contributing to immune escape.
Supporting Evidence
- Thyroid cancer cells secrete cytokines that increase PDL-1 expression.
- IL-6, IL-8, and CXCL1 were found to induce PDL-1 expression in thyroid cancer cells.
- Conditioned medium from thyroid cancer cells significantly increased PDL-1 expression.
- STAT3 pathway activation is crucial for PDL-1 expression in thyroid cancer cells.
- Lactate produced by tumor cells also contributes to increased PDL-1 expression.
Takeaway
Thyroid cancer cells can make substances that help them hide from the immune system, making it harder for the body to fight the cancer.
Methodology
The study involved cell culture, RT-PCR, Western blotting, and ELISA to analyze PDL-1 expression and the effects of various cytokines.
Limitations
The use of chemical inhibitors may block other signaling molecules regulating PDL-1.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website